These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 20374326

  • 1. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [Abstract] [Full Text] [Related]

  • 2. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD, Patwardhan MM, Ghosh K.
    Indian J Dermatol Venereol Leprol; 2010 Jul; 76(2):145-9. PubMed ID: 20228543
    [Abstract] [Full Text] [Related]

  • 3. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA, Koutouzov S, Mota RM, das Chagas Medeiros MM, Bach JF, de Holanda Campos H.
    J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
    [Abstract] [Full Text] [Related]

  • 5. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 6. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y, Jia RL, Han L, Li ZG.
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [Abstract] [Full Text] [Related]

  • 7. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 8. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC, Malone CC, Meyers C, Decker P, Muller S.
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [Abstract] [Full Text] [Related]

  • 12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Jan; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 13. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Jan; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 14. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F.
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [Abstract] [Full Text] [Related]

  • 15. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
    Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P.
    Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
    [Abstract] [Full Text] [Related]

  • 16. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
    Massardo L, Martínez ME, Pérez R, Ramírez V, Foradori A, González A, Radrigán F, Gutiérrez F, Jacobelli S.
    Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
    [Abstract] [Full Text] [Related]

  • 17. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of a new quantitative enzyme-linked immunosorbent assay for detection of double-stranded DNA autoantibodies.
    Bardin N, Ragot C, Sanmarco M.
    Ann N Y Acad Sci; 2007 Aug; 1109():511-8. PubMed ID: 17785340
    [Abstract] [Full Text] [Related]

  • 20. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S, Harper J, Kiely PD.
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.